Navigation Links
Ambit Biosciences Provides Regulatory Update Following FDA Meeting Regarding Quizartinib (AC220)
Date:12/3/2013

garding future development and therapeutic potential of quizartinib and Ambit's other drug candidates, progress and timing of Ambit's drug development programs, including the submission of regulatory filings and planned discussions with regulatory bodies, plans regarding future clinical trials of quizartinib, including the starting dose for the Phase 3 clinical trial, and Ambit's other drug candidates, the progress and expected timing of clinical trials including the timing of initiation of the Phase 3 clinical trial, the presentation of data from clinical trials, the clinical benefits to be derived from quizartinib and Ambit's other drug candidates and  the regulatory approval path for quizartinib. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as  "plans," "expects," "anticipates," "hopes", "may," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Ambit's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. These and other risks concerning Ambit's programs are described in additional detail in Ambit's SEC filings. All forward-looking statements contained in this press release speak only as of the date on which they were made. Ambit undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were
'/>"/>
SOURCE Ambit Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ambit Biosciences to Announce Third Quarter 2013 Financial and Operating Results and Conference Call
2. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
3. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
4. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
5. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
6. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
7. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
8. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
9. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
10. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
11. Neodyne Biosciences Announces Issuance of U.S. Patent for Devices and Methods for Dressing Applicators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... KENNEWICK, Wash. , Dec. 19, 2014 /PRNewswire/ ... late stage development company engaged primarily in the ... diagnostic and therapeutic applications, today announced that a ... Grant has been awarded for which AMIC is ... Washington State University (WSU) for the proposal titled ...
(Date:12/19/2014)... 19, 2014  Monarch America Inc. (OTCQB: CANK) ("Monarch ... pleased to provide this review of the Company,s recent ... "Over this past year, we achieved many ... extremely proud to say that Monarch America is in ... has ever been," stated Eric Hagen , CEO ...
(Date:12/19/2014)... LOS ALTOS, Calif. , Dec. 18, 2014 ... of a new generation of equipment for the ... today the release of the new Luminary™ Profiler, ... highly accurate light-based measurement in a cost-effective, portable ... to meet the specific needs of the cannabis ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
... , MORGANTOWN, W.Va. , Feb. 12 ... of surgical technologies, medical devices and telehealth programs. , ... programs can support nursing care providers in a variety ... by adding an extra layer of providers (remotely). ...
... WASHINGTON , Feb. 12 Members of ... a quick recovery following his recent hospitalization for angioplasty ... communicated a desire to return to work promptly. Because angioplasty ... chest, most patients who receive coronary stents leave the hospital ...
Cached Medicine Technology:SCAI Statement on the Hospitalization of Former President Bill Clinton 2
(Date:12/20/2014)... 20, 2014 Recently, AngelWeddingDress.com has introduced ... ”) for the coming Christmas. In the promotion, all ... off. , “We have something special for the women ... holiday season. Moreover, our new collections of 2015 dresses ... offered now at greatly discounted prices. Visit our website ...
(Date:12/20/2014)... Today, Balfleet.com, one of the most outstanding ... 50%-70% off on its Mother of the Bride ... of the bride dresses from Balfleet.com feature gorgeous looks ... and takes pride in providing high quality dresses to ... great discounts on our mother of the bride dresses, ...
(Date:12/19/2014)... Energy Textiles is excited to ... Celliant, the world’s leading responsive textile, can now ... There are a number of benefits to wearing ... and balanced body temperature; which can lead to ... enhanced athletic performance; and overall wellness. In addition, ...
(Date:12/19/2014)... These vanadium reserves are mostly found ... 151,000 tons of vanadium were produced globally in 2013, ... increased at 6.7% AAGR during the period from 2001 ... being the largest consumer, accounted for more than 90% ... alloy and the chemical industry. , View Full Report ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- The intestinal bacteria that ... ulcerative colitis, may be inherited, researchers report. The ... , could help in efforts to prevent the disease ... colitis, the study authors added. "The intestinal bacteria, ... age can have a big impact on your health ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2
... new cases of bird flu in the impoverished Southeast Asian ... victory over bird flu with no new outbreaks of the ... official media report that has been. Yangon notified the world ... the H5N1 virus, which first emerged in central Myanmar in ...
... JAMA, The Journal of the American Medical Association finds ... hard as ever. Doctors' training, or// residency includes shifts ... Accreditation Council for Graduate Medical Education (ACGME) say that ... MD, MPH, of Harvard Medical School, and colleagues said ...
... in Delhi Wednesday said they were fully prepared to deal ... ignorance about three cases being detected// in the city. ... detected in Delhi. Since the disease is quite similar to ... with the viral infection," said N.K. Yadav, additional municipal health ...
... leader in oral care, in association with the Indian ... observed as Oral Health Month. Now in its third ... oral health awareness campaign in India to establish and ... all ages. This year, the theme of Oral Health ...
... could be dying due to respiratory diseases including asthma.// ... conducted this study, according to which, some deaths and ... are not reported. ,Shortness of breath, wheezing, ... asthma, a chronic respiratory condition. COPD is too a ...
... of the Scottish Executive Health experts, NHS forth valley has ... programme, which will necessitate and all babies under the age ... against a lethal meningitis form. The number of doses ... children. ,Nearly 700 cases of meningitis and septicemia ...
Cached Medicine News:Health News:Myanmar Declares Herself As A Country Free of Bird flu 2Health News:Delhi Gears up to Fight Chikungunya Fever 2Health News:Striving to Make India Free from Tooth Decay 2Health News:Asthma –an underlying or associated cause of death 2
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size....
The rectangular large-field lens of the 2631 are ideal for reading and writing....
Thinprofile design eyelid implants....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Medicine Products: